LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, Marketbeat reports.
The Vascular Institute of Chattanooga invited us into the outpatient room for a look at some tech that’s changing lives here in the Tennessee Valley. Dr. Chris LeSar is one of the top vascular ...
If you have recently been diagnosed with vascular dementia, this booklet is for you. It will help you, and your family and friends, to understand more about the condition and how it can affect you.
Solaris develops its flagship SX vascular stent graft as a minimally invasive treatment for these conditions. It employs an advanced electrospinning PTFE impermeable membrane that prevents tissue ...